Search - tctmd.com

Displaying 341 - 355 of 355

Sort: Relevancy | Date

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Industry News

Boston Scientific Announces its ACC 2011 Schedule

March 29, 2011

News Industry News

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

March 28, 2011

News Industry News

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

March 28, 2011

News Daily News

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

L.A. McKeown

March 10, 2011

News Daily News

Women Less Likely to Receive Evidence-Based Therapies Than Men

Jason Kahn

March 09, 2011

News Daily News

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

L.A. McKeown

February 28, 2011

News Daily News

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Jason Kahn

February 23, 2011

News Daily News

In-Hospital Mortality Equal for Men, Women After PCI for STEMI

Caitlin E. Cox

February 08, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

News Industry News

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

January 09, 2011

Partner Content

The XIENCE Fluoropolymer's Unique Properties May Allow for Shorter DAPT

November 15, 2016

Partner Content

The Uniqe Safety of the XIENCE Fluoropolymer Implications for Your Clinical Practice

September 30, 2016

Advertisement

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Boston Scientific Announces its ACC 2011 Schedule

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

Women Less Likely to Receive Evidence-Based Therapies Than Men

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

In-Hospital Mortality Equal for Men, Women After PCI for STEMI

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

The XIENCE Fluoropolymer's Unique Properties May Allow for Shorter DAPT

The Uniqe Safety of the XIENCE Fluoropolymer Implications for Your Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content